Thema: NL0015002SN0
Qiagen, NL0015002SN0
Qiagen N.V. (NL0012169213) Pipette tropft klare Flüssigkeit in sterile 96-Well-Platte im klinischen Labor - Foto: THN
Qiagen stock after-hours: EUR 39.63, prior close EUR 40.12
Qiagen stock was at EUR 39.63 after-hours at Lang & Schwarz at 6:17 p.m. CEST on October 8, 2026, down 1.22 percent versus the October 7 close.
ad-hoc-news.de, heute 18:28 Uhr
Qiagen, NL0015002SN0
Qiagen stock falls to EUR 39.05 with a 22.4 P / E ratio
Qiagen stock costs EUR 39.05 on October 8, 2026 after EUR 40.12, down 2.67 percent. Its P/E ratio is 22.4.
ad-hoc-news.de, heute 16:16 Uhr
Qiagen, NL0015002SN0
Takeover talks advanced. Qiagen stock traded 1.15 percent ...
Second-quarter revenue beat consensus at USD 535.04 million by USD 7.54 million. Qiagen stock costs EUR 39.66 on October 8, 2026 after EUR 40.12.
ad-hoc-news.de, heute 11:19 Uhr
Qiagen, NL0015002SN0
Qiagen stock gets a new AI growth story from QIAGEN
Qiagen stock gets a new AI growth story as QIAGEN launches two bioinformatics platforms on October 7, 2026. Q2 adjusted EPS reached USD 0.62.
ad-hoc-news.de, 07.10.26 13:54 Uhr
Qiagen, NL0015002SN0
Barclays raises target for Qiagen stock from USD 40.00 to ...
Qiagen stock costs EUR 40.78 on October 7, 2026 versus EUR 40.58, plus 0.49 percent. Second-quarter sales reached USD 535.00 million.
ad-hoc-news.de, 07.10.26 10:06 Uhr
Qiagen, NL0015002SN0
Qiagen stock: no euro price stated; FDA clearance expands ...
Qiagen stock: no euro price is stated here. On September 28, 2026, Qiagen said FDA clearance completed its U.S. QIAstat-Dx bloodstream infection portfolio.
ad-hoc-news.de, 06.10.26 18:10 Uhr
Qiagen, NL0015002SN0
Qiagen calls shareholder meeting. Qiagen stock gains 1.50 ...
Qiagen posted USD 535.04 million revenue, above USD 527.50 million estimates. Qiagen stock costs EUR 41.37 on October 6, 2026 after EUR 40.76.
ad-hoc-news.de, 06.10.26 10:29 Uhr
